Symbol="PTGX"
AssetType="Common Stock"
Name="Protagonist Therapeutics Inc"
Description="Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California."
CIK="1377121"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1098080000"
EBITDA="-146183008"
PERatio="None"
PEGRatio="0"
BookValue="5.12"
DividendPerShare="0"
DividendYield="0"
EPS="-2.75"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.292"
ReturnOnEquityTTM="-0.49"
RevenueTTM="0"
GrossProfitTTM="26581000"
DilutedEPSTTM="-2.75"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="39.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="13.27"
PriceToBookRatio="1.925"
EVToRevenue="5.84"
EVToEBITDA="-1.604"
Beta="1.887"
num_52WeekHigh="30.1"
num_52WeekLow="7.24"
num_50DayMovingAverage="24.33"
num_200DayMovingAverage="17.63"
SharesOutstanding="57251000"
DividendDate="None"
ExDividendDate="None"
symbol="PTGX"
open="18.53"
high="19.46"
low="18.31"
price="19.18"
volume="701066.00"
latest_trading_day="2023-08-04"
previous_close="18.57"
change="0.61"
change_percent="3.2849%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="24"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="76"
Volume_recent_avg="1170035"
Change_recent_avg="-0.09"
Delta_recent_avg="1.27"
Variance_recent_avg="0.63"
Change_ratio_recent_avg="-0.45"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="76"
Aroon_momentum_negative="24"
image_negative_thumbnail_id_1="109"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0067.jpeg"
image_negative_thumbnail_id_2="1103"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_neutral_thumbnail_id_1="571"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0028.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="1007"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0169.jpeg"
image_positive_thumbnail_id_2="660"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0048.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1174"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
